ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DPH Dechra Pharmaceuticals Plc

3,866.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Dechra Pharmaceuticals Plc LSE:DPH London Ordinary Share GB0009633180 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3,866.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Dechra Pharmaceuticals PLC 2018 Annual Report (7366Z)

04/09/2018 1:05pm

UK Regulatory


Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Dechra Pharmaceuticals Charts.

TIDMDPH

RNS Number : 7366Z

Dechra Pharmaceuticals PLC

04 September 2018

4 September 2018

Dechra(R) Pharmaceuticals PLC

(Dechra or the Company)

Availability of 2018 Annual Report and Accounts

The 2018 Annual Report and Accounts is now available to view at www.dechra.com.

The following documents are scheduled to be mailed to registered shareholders of the Company on 17 September 2018:

   --      2018 Annual Report and Accounts 
   --      Notice of the 2018 Annual General Meeting; and 
   --      Proxy Form for the 2018 Annual General Meeting. 

In accordance with Listing Rule 9.6.1 a copy of each of these documents will be submitted to the National Storage Mechanism and will be available for viewing shortly after posting.

For further information, please contact:

Melanie Hall

Company Secretary

Telephone: +44 (0) 1606 814730

e-mail: corporate.enquiries@dechra.com

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ACSLLFIFAFISIIT

(END) Dow Jones Newswires

September 04, 2018 08:05 ET (12:05 GMT)

1 Year Dechra Pharmaceuticals Chart

1 Year Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock